Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer

The Highs and Lows of FAIMS: Predictions and Future Trends for High Field Asymmetric Waveform Ion Mobility Spectrometry

View More »

Google Scholar citation report
Citations : 8261

Journal of Nanomedicine & Nanotechnology received 8261 citations as per Google Scholar report

Flyer image
Journal of Nanomedicine & Nanotechnology peer review process verified at publons
Flyer image
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • Scientific Indexing Services (SIS)
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Flyer image
Open Access Journals
View More
A clinical trial to evaluate the safety and immunogenicity of a novel DNA vaccine used as immunotherapy during leishmaniasis
4th International Conference on Nanotek & Expo
December 01-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Laura Manna

Scientific Tracks Abstracts: J Nanomed Nanotechnol

Abstract:

Twenty leishmaniotic dogs from a leishmaniasis-endemic area (Naples, Italy) were enrolled in a clinical trial and were randomly assigned to receive three consecutive subcutaneous injections of vaccine at 10-days intervals (n=10\20), saline placebo (n=10\20). The vaccine was safe and well tolerated. Leishmania DNA load, IFAT, INF-λ and IL4 mRNA expression levels were tested before and after the immunotherapy, every 3 months for a period of 12 months. Analysis of the data indicated that the vaccine was safe and immunogenic in CVL dogs.

Biography :

Laura Manna has completed her PhD at the age of 28 years from Naples University and Postdoctoral studies from Naples University School of Veterinary Medicine. From 2005 she is a Researcher of Department of Veterinary Medicine and Animal Productions of University of Naples. Her research interest is to develop a protective vaccine for the prevention and treatment of leishmaniasis. She has published more than 25 papers in reputed journals.

PDF HTML